The findings imply that the levels of selected neurotrophins (BDNF and NT4/5), heat shock proteins (HSP70 and HSP27), SIRT1, and selected miRNAs in PBMC cells may function as biomarkers of inflammation in the CNS and neurodegenerative processes in MS patients. Here, NTF4 is linked to myeloid sarcoma.